Value of Serum NGAL Combined with Serum Cystatin C for Predicting Acute Kidney Injury in Preterm Neonates with Respiratory Distress Syndrome
Diab, A., Abdelmotaleb, G., Rashed, M., Abd Elateef, W., Elshaarawy, F., Affi, W. (2022). Value of Serum NGAL Combined with Serum Cystatin C for Predicting Acute Kidney Injury in Preterm Neonates with Respiratory Distress Syndrome. EKB Journal Management System, 89(2), 6895-6901. doi: 10.21608/ejhm.2022.271908
Aliaa M. Diab; Ghada S. Abdelmotaleb; Mosad Fatouh Rashed; Waled Abd Elateef; Fatma S. Elshaarawy; Wesam E. Affi. "Value of Serum NGAL Combined with Serum Cystatin C for Predicting Acute Kidney Injury in Preterm Neonates with Respiratory Distress Syndrome". EKB Journal Management System, 89, 2, 2022, 6895-6901. doi: 10.21608/ejhm.2022.271908
Diab, A., Abdelmotaleb, G., Rashed, M., Abd Elateef, W., Elshaarawy, F., Affi, W. (2022). 'Value of Serum NGAL Combined with Serum Cystatin C for Predicting Acute Kidney Injury in Preterm Neonates with Respiratory Distress Syndrome', EKB Journal Management System, 89(2), pp. 6895-6901. doi: 10.21608/ejhm.2022.271908
Diab, A., Abdelmotaleb, G., Rashed, M., Abd Elateef, W., Elshaarawy, F., Affi, W. Value of Serum NGAL Combined with Serum Cystatin C for Predicting Acute Kidney Injury in Preterm Neonates with Respiratory Distress Syndrome. EKB Journal Management System, 2022; 89(2): 6895-6901. doi: 10.21608/ejhm.2022.271908

Value of Serum NGAL Combined with Serum Cystatin C for Predicting Acute Kidney Injury in Preterm Neonates with Respiratory Distress Syndrome

The Egyptian Journal of Hospital Medicine
Article 122, Volume 89, Issue 2, October 2022, Page 6895-6901  XML PDF (406.68 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2022.271908
View on SCiNiTO View on SCiNiTO
Authors
Aliaa M. Diab; Ghada S. Abdelmotaleb; Mosad Fatouh Rashed; Waled Abd Elateef; Fatma S. Elshaarawy; Wesam E. Affi email
Abstract
Background: The most frequent cause of respiratory failure in preterm newborns, as well as the most frequent cause of mortality and long-term morbidity associated with prematurity, is respiratory distress syndrome (RDS). RDS affects half of newborns with birth weights (BW) under 1.5 kg, and a sizable portion of those newborns also experience acute kidney injury (AKI). Objective: The purpose of this study was to identify useful biomarkers (serum cystatin C andNeutrophil gelatinase-associated lipocalin (NGAL) to predict AKI in premature infant with RDS.
Patients and Methods: This was a prospective (case-control) study was conducted on 90 preterm neonates between 28 and 36 gestational weeks (GW) from the neonatal intensive care unit (NICU) of Benha University hospitals.  Serum creatinine, Blood urea nitrogen Levels, Serum cystatin C and Serum NGAL were measured for all included neonates.  Results: Serum creatinine showed no significant difference between the studied groups at day 3 (P = 0.273). At day 5 and day 7, it was significantly higher in group I (1.4 & 1.8 mg/dl, respectively) than groups II (0.7 & 0.6 mg/dl, respectively) and III (0.6 & 0.5 mg/dl, respectively). Also, it was significantly higher in group II (0.7 & 0.6 mg/dl, respectively) than group III (0.6 & 0.5 mg/dl, respectively). Serum cystatin C and serumNGAL showed an overall significant difference between the studied groups at day 3 (P < 0.001). In post hoc analyses, it was significantly higher in group I (1.7 mg/l) than groups II (1.1 mg/l) and III (01 mg/l). Conclusion: NGAL and sCys C levels were found to have a statistically significant association with development of AKI in preterm neonates with RDS and they were elevated earlier than sCr which makes NGAL and sCys C a good predictive marker for AKI in preterm neonates better than sCr.
 
Keywords
Serum NGAL; Serum Cystatin C; Acute kidney injury; Respiratory Distress Syndrome
Statistics
Article View: 147
PDF Download: 217